Latest Intas Pharmaceuticals Ltd. News | Intas Pharmaceuticals Ltd. News | Intas Pharmaceuticals Ltd. Funding | Intas Pharmaceuticals Ltd. Fund - vccircle
Advertisement

Intas Pharmaceuticals Ltd.

What the CCI's concerns over common ownership mean for private equity deals

Opinion

12 February, 2025

What the CCI's concerns over common ownership mean for private equity deals

Gone are the days when private equity investments were considered entirely benign from an antitrust perspective. Over the last five ......

ChrysCapital-backed Intas Pharma strikes another overseas acquisition

Healthcare

07 January, 2025

ChrysCapital-backed Intas Pharma strikes another overseas acquisition

Gujarat-based drugmaker Intas Pharmaceuticals Ltd., which counts private equity firm ChrysCapital, Singapore state investment firm Temasek and Abu Dhabi Investment ......

Premium
Bottomline: ChrysCap, SWFs-backed Intas Pharma facing headwinds

Healthcare

05 January, 2024

Bottomline: ChrysCap, SWFs-backed Intas Pharma facing headwinds

Gujarat-based drugmaker Intas Pharmaceuticals Ltd has had a nearly three-decade-long tryst with private equity investors, having raised capital from ICICI ......

Premium
ChrysCapital-backed Intas Pharma weighs $1-bn bid for Biogen's biosimilars biz

Healthcare

13 September, 2023

ChrysCapital-backed Intas Pharma weighs $1-bn bid for Biogen's biosimilars biz

Intas Pharmaceuticals Ltd is preparing a bid for Biogen Inc.’s biosimilar business in a transaction that could be valued at ......

Premium
Ascent-backed Naari to acquire drug applications portfolio to boost US biz

Healthcare

08 June, 2020

Ascent-backed Naari to acquire drug applications portfolio to boost US biz

Ascent Capital-backed Naari Pharma Pvt. Ltd is set to acquire a portfolio of abbreviated new drug applications (ANDAs) from a ......

Premium
How PE and M&A dealmaking turned out in healthcare sector in Jan-March

Finance

09 April, 2020

How PE and M&A dealmaking turned out in healthcare sector in Jan-March

India’s healthcare sector recorded fewer private equity transactions as well as mergers and acquisitions in the first quarter of 2020 ......

Premium
ChrysCapital set to reinvest in another pharmaceutical portfolio firm

Healthcare

22 January, 2020

ChrysCapital set to reinvest in another pharmaceutical portfolio firm

Homegrown private equity firm ChrysCapital is in advanced talks to increase its stake in its oldest pharmaceutical portfolio company, which ......

Premium
Aurobindo Pharma ends big-ticket bid for Mallinckrodt's generics biz

Healthcare

26 October, 2017

Aurobindo Pharma ends big-ticket bid for Mallinckrodt's generics biz

Drugmaker Aurobindo Pharma Ltd has walked away from the race to purchase the generics business of UK-based Mallinckrodt Plc in ......

Premium
Temasek-backed Intas triumphs in trademark battle against rival

Healthcare

26 May, 2017

Temasek-backed Intas triumphs in trademark battle against rival

The Bombay High Court has dismissed a case against Intas Pharmaceuticals Ltd filed by a rival drugmaker alleging violation of ......

Premium
Company watch: PE-backed Intas Pharma enjoying a healthy dose of growth

Healthcare

17 April, 2017

Company watch: PE-backed Intas Pharma enjoying a healthy dose of growth

It was in 1996 that Intas Pharmaceuticals Ltd first attracted a private equity investor. Twenty-one years later, PE firms’ interest ......

Advertisement

Most Popular

Advertisement
Google News Icon

Google News

Follow VCCircle on Google News for the latest updates on Business and Startup News